GOLPH3 is highly expressed in samples from NSCLC patients, and overexpression of GOLPH3 enhances metastasis and tumorigenicity by activating the WNT/β-catenin pathway (Song et al., 2021). The gene discussed is GOLPH3; the disease is non-small cell lung carcinoma.